These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Estrogen formation in endometrial and cervix cancer cell lines: involvement of aromatase, steroid sulfatase and 17beta-hydroxysteroid dehydrogenases (types 1, 5, 7 and 12). Fournier MA, Poirier D. Mol Cell Endocrinol; 2009 Mar 25; 301(1-2):142-5. PubMed ID: 18817841 [Abstract] [Full Text] [Related]
7. Endocrine factors in the etiology of endometrial carcinoma. Gimes G, Szarvas Z, Siklósi G. Neoplasma; 1986 Mar 25; 33(3):393-7. PubMed ID: 2942790 [Abstract] [Full Text] [Related]
8. Aromatase in human endometrial carcinoma and hyperplasia. Immunohistochemical, in situ hybridization, and biochemical studies. Watanabe K, Sasano H, Harada N, Ozaki M, Niikura H, Sato S, Yajima A. Am J Pathol; 1995 Feb 25; 146(2):491-500. PubMed ID: 7856758 [Abstract] [Full Text] [Related]
9. [Specifics of hormonal and energy balance in patients with hyperplasia and endometrial neoplasia with metabolic syndrome in the background]. Chernyshova AL, Kolomiets LA, Bochkarëva NV, Kondakova IV. Vopr Onkol; 2013 Feb 25; 59(1):65-71. PubMed ID: 23814828 [Abstract] [Full Text] [Related]
10. Steroid metabolism in breast cancer. Foster PA. Minerva Endocrinol; 2008 Mar 25; 33(1):27-37. PubMed ID: 18277377 [Abstract] [Full Text] [Related]
11. Expression analysis of the genes involved in estradiol and progesterone action in human ovarian endometriosis. Smuc T, Pucelj MR, Sinkovec J, Husen B, Thole H, Lanisnik Rizner T. Gynecol Endocrinol; 2007 Feb 25; 23(2):105-11. PubMed ID: 17454161 [Abstract] [Full Text] [Related]
14. Case-control study of endogenous steroid hormones and endometrial cancer. Potischman N, Hoover RN, Brinton LA, Siiteri P, Dorgan JF, Swanson CA, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD, Persky V, Lurain JR. J Natl Cancer Inst; 1996 Aug 21; 88(16):1127-35. PubMed ID: 8757192 [Abstract] [Full Text] [Related]
15. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Kaaks R, Lukanova A, Kurzer MS. Cancer Epidemiol Biomarkers Prev; 2002 Dec 21; 11(12):1531-43. PubMed ID: 12496040 [Abstract] [Full Text] [Related]
16. [Tumor tissue aromatase and estrogen levels versus clinical course of endometrial cancer]. Bersteĭn LM, Chernobrovkina AE, Gamaiunova VB, Vasil'ev DA, Kovalevskiĭ AIu, Maksimov SIa, Chepik OF, Gershfel'd ED. Vopr Onkol; 2003 Dec 21; 49(1):55-9. PubMed ID: 12715371 [Abstract] [Full Text] [Related]
17. Synthesis of highly tritium labeled steroids for evaluation of aromatase and steroidsulfatase activities in endometrial tumors. Bochkareva NV, Kondakova IV, Kolomiets LA, Muntyan AB, Shevchenko VP, Nagaev IY, Shevchenko KV, Myasoedov NF, Dorofeeva NN. Bull Exp Biol Med; 2006 Oct 21; 142(4):478-80. PubMed ID: 17415442 [Abstract] [Full Text] [Related]
18. Steroid sulfatase and estrogen sulfotransferase in colon carcinoma: regulators of intratumoral estrogen concentrations and potent prognostic factors. Sato R, Suzuki T, Katayose Y, Miura K, Shiiba K, Tateno H, Miki Y, Akahira J, Kamogawa Y, Nagasaki S, Yamamoto K, Ii T, Egawa S, Evans DB, Unno M, Sasano H. Cancer Res; 2009 Feb 01; 69(3):914-22. PubMed ID: 19141651 [Abstract] [Full Text] [Related]